Ilaris smpc
WebSummary of product characteristics A document describing the properties and the officially approved conditions of use of a medicine. Summaries of product characteristics form the … WebIlaris wird für die Behandlung des familiären Mittelmeerfiebers (FMF) angewendet. Ilaris sollte gegebenenfalls in Kombination mit Colchicin verabreicht werden. Ilaris wird auch …
Ilaris smpc
Did you know?
WebCanakinumab, sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis and active Still's disease, including adult-onset Still's disease. [4] [5] It is a human monoclonal antibody targeted at interleukin-1 beta. Web17 sep. 2024 · Ilaris is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents and children aged 2 years and older: Cryopyrin …
WebILARIS® can be used alone or in combination with methotrexate (text in italic: in the EU SmPC). It is suitable for adults and children aged 2 years and older with body weight of … WebSmPC and relevant sections of the PL with the results of study CACZ885GDE01T (a multi-centre, phase II, randomized, placebo-controlled trial of Ilaris for the Treatment of adult …
Web16 dec. 2024 · Ilaris 150mg/ml Solution for Injection Active Ingredient: canakinumab Company: Novartis Pharmaceuticals UK Ltd See contact details ATC code: L04AC08 … Web16 jun. 2024 · Healthcare Professionals (SmPC) Patient Leaflet (PIL) This information is for use by healthcare professionals Last updated on emc: 16 Jun 2024 Quick Links Undesirable Effects Pharmacological Properties Interactions Posology Contraindications Excipients Print SmPC information Expand All This medicinal product is subject to additional monitoring.
WebIlaris is indicated for the treatment of hyperimmunoglobulin D syndrome (HIDS)/mevalonate kinase deficiency (MKD). Familial Mediterranean fever (FMF) Ilaris is indicated for the …
Webcanakinumab vergelijken met een ander geneesmiddel.. Advies. Stimuleer ter preventie van (verergering van) met jicht geassocieerde cardiovasculaire en metabole aandoeningen … dan olson folding ideas imdbWebHome Onderwerpen Samenvatting van de productkenmerken (SmPC) Open zoekveld Nieuws Documenten In 2005 heeft de Europese Commissie de "Guideline on Summary of Product Characteristics, October 2005" vastgesteld met algemene richtlijnen voor de wijze waarop informatie moet worden vermeld in de SmPC. birthday names imagesWebPermanently discontinue MEKINIST for patients diagnosed with treatment-related ILD or pneumonitis. Serious Febrile Reactions. Serious febrile reactions or fever of any severity complicated by hypotension, rigors or chills, dehydration, or renal failure can occur with TAFINLAR and MEKINIST. d a nolt inc berlin njWebILARIS Powder for solution for injection Overview - MPI, EU: SmPC - Rx Reasoner. Verifiable medication recommendations by combining scientific data with health records. … dan olson folding ideas eventsWeb6 jul. 2024 · Ilaris is indicated for the treatment of active Still's disease including adult-onset Still's disease (AOSD) and systemic juvenile idiopathic arthritis (SJIA) in patients aged 2 … dan olson shelton waWebHuman medicines. Medicinal product information search platform (AIPS) with information for authorised human medicines. www.swissmedicinfo.ch. birthday name tags printable freeWebYondelis 0.25 mg powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC) - (emc) Yondelis 0.25 mg powder for concentrate for solution for infusion Active Ingredient: trabectedin Company: Immedica See contact details ATC code: L01CX01 About Medicine Prescription only medicine birthday napkins custom